Strategic R&D leader with 25 years’ experience in cancer research, oncology drug discovery and development, and business and research strategies

Extensive experience in fund raising efforts via institutional grants, venture capital & IPO, as well as in strategic planning of scientific and corporate goals

Expertise in areas of drug discovery & lead identification, in vitro and in vivo pharmacology, translational research, PK/PD, biomarkers, clinical research, molecular mechanisms of cancer, preclinical models of cancer, molecular imaging, and bioanalytical assay development

Author of >35 peer-reviewed scientific articles, inventor of >15 patent application families, recipient of grants from the National Institutes of Health and the Cancer Prevention Research Institute of Texas